KTTA vs MSFT: Which Stock is Better?
Side-by-side comparison of Pasithea Therapeutics Corp and Microsoft Corp in 2026
KTTA
Pasithea Therapeutics Corp
$0.74
MSFT
Microsoft Corp
$422.50
Key Metrics Comparison
| Metric | KTTA | MSFT | Winner |
|---|---|---|---|
| Market Cap | $18.52M | N/A | KTTA |
| P/E Ratio | N/A | 26.31 | MSFT |
| EPS (TTM) | $N/A | $16.07 | MSFT |
| Revenue Growth | 15.0% | 0.2% | KTTA |
| Gross Margin | -0.5% | 68.6% | MSFT |
Analyze KTTA
Full quant analysis
Analyze MSFT
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is KTTA or MSFT a better investment?
Comparing KTTA and MSFT: Pasithea Therapeutics Corp has a market cap of $18.52M while Microsoft Corp has N/A. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between KTTA and MSFT?
KTTA (Pasithea Therapeutics Corp) and MSFT (Microsoft Corp) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: KTTA or MSFT?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: KTTA or MSFT?
KTTA has higher revenue growth at 15.0% vs 0.2% for MSFT.
Which company is more profitable: KTTA or MSFT?
Microsoft Corp (MSFT) has higher gross margins at 68.6% compared to -0.5% for KTTA.
Which is the larger company: KTTA or MSFT?
Pasithea Therapeutics Corp (KTTA) is larger with a market cap of $18.52M compared to N/A for MSFT.
Should I buy KTTA or MSFT in 2026?
Both KTTA and MSFT have investment merit. KTTA trades at $0.74 while MSFT trades at $422.50. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between KTTA and MSFT stock?
Key differences: Market Cap ($18.52M vs N/A), P/E Ratio (N/A vs 26.3x), Revenue Growth (15.0% vs 0.2%), Gross Margin (-0.5% vs 68.6%).